Progress of Biomarkers in Diagnosis of Bone Metastases of Lung Cancer
Bone is one of the most metastatic sites of advanced malignant tumors. With the continuous improvement of diagnosis and treatment of malignant tumors, the survival time of patients is prolonged and incidence of bone metastases also increases. Lung cancer is the leading cause of cancer-related mortal...
Main Authors: | Chao MENG, Chuanhao TANG, Jun LIANG |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2018-08-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2018.08.07 |
Similar Items
-
Establishment of a regression model of bone metabolism markers for the diagnosis of bone metastases in lung cancer
by: Zhongliang Zhu, et al.
Published: (2021-01-01) -
Characteristics and Treatment of Bone Metastases in 322 Cases Non-small Cell Lung Cancer: A Retrospective Study
by: Qingzhi GUO, et al.
Published: (2014-09-01) -
Progress of Treatments in Non-small Cell Lung Cancer with Brain Metastases
by: Chunhua MA, et al.
Published: (2012-05-01) -
Diagnostic Value of Bone Metabolic Markers ICTP and BAP in Lung Cancer Patients with Bone Metastases
by: Yu XIN, et al.
Published: (2010-10-01) -
Research Progress of Targeted Therapy in Non-small Cell Lung Cancer Brain Metastases
by: Tao JIANG, et al.
Published: (2014-11-01)